How much funding has Proscia raised?

Proscia has raised $118.3M in total funding, most recently a Series C round.

Who are Proscia's investors?

Proscia's investors include Insight Partners, Scale Venture Partners, Triangle Peak Partners, AI Capital Partners, Highline Capital Management, Alpha Intelligence Capital.

Where is Proscia headquartered?

Proscia is headquartered in Philadelphia, Pennsylvania, United States.

What industry is Proscia in?

Proscia operates in Artificial Intelligence, Biotech, Healthcare.

Proscia

Rewiring pathology for precision medicine

Philadelphia, United States · Founded 2014 · $118.3M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: Philadelphia, Pennsylvania
Employees: 51–200
Founded: 2014
Business Model: B2B

Website: proscia.com
Total Funding: $118.3M
Last Round: $50.0M Series CMar 2025
Rounds: 4

About

Proscia is a Philadelphia-based digital pathology software company founded in 2014 by David West, Coleman Stavish, and Nathan Buchbinder. The company's Concentriq platform is an enterprise digital pathology system used by more than 12,000 pathologists and scientists daily at reference labs, academic medical centers, CROs, and 16 of the top 20 global pharma companies. Concentriq offers purpose-built products for life sciences research, anatomic pathology digitization, and FDA-cleared primary diagnosis. Proscia also offers Aperture, a precision medicine solution for drug development and real-world evidence generation.

Summary

Proscia is an Artificial Intelligence company based in Philadelphia, United States, founded in 2014. It has raised $118.3M in total across 4 rounds, most recently a $50.0M Series C round in Mar 2025. Investors include Insight Partners, Scale Venture Partners and Triangle Peak Partners.

LinkedIn X (Twitter)